Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 22

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 3
Chunk 22
---
 with the terms of future
financing arrangements could result in default, which could have an adverse effect on NewGenIvf’s cash flow and liquidity.

NewGenIvf may from time to
time enter into credit facilities and debt financing arrangements containing financial and other covenants that could, among other things,
restrict NewGenIvf’s business and operations. If NewGenIvf breaches any of these covenants, including the failure to maintain certain
financial ratios, NewGenIvf’s lenders may be entitled to accelerate NewGenIvf’s debt obligations. Any default under the credit
facility could result in the repayment of these loans prior to maturity as well as the inability to obtain additional financing, which
in turn may have a material adverse effect on NewGenIvf’s cash flow and liquidity.

NewGenIvf requires a significant amount
of capital to fund its operations and growth. If NewGenIvf cannot obtain sufficient capital on acceptable terms, its business, financial
condition, and prospects may be materially and adversely affected.

NewGenIvf requires a significant
amount of capital and resources for its operations and continued growth. NewGenIvf expects to make significant investments to fund operations,
laboratory upgrades, among other things, which may significantly increase NewGenIvf’s net cash used in operating activities. In
addition, NewGenIvf will continue to invest in laboratory and facilities which are fundamental to NewGenIvf’s business operation
and future growth. However, NewGenIvf cannot assure you that these investments will generate the optimal returns, if at all. To date,
NewGenIvf has historically funded its cash requirements primarily through operational, capital contributions from its shareholders and
short-term or long-term borrowings. If these resources are insufficient to satisfy NewGenIvf’s cash requirements, NewGenIvf may
seek to raise funds through additional equity offering or debt financing or additional bank facilities. NewGenIvf’s ability to obtain
additional capital in the future, however, is subject to a number of uncertainties, including those relating to its future business development,
financial condition, and results of operations, general market conditions for financing activities by companies in its industry, and macro-economic
and other conditions in Thailand, Cambodia, Kyrgyzstan and globally. If NewGenIvf cannot obtain sufficient capital on acceptable terms
to meet its capital needs, NewGenIvf may not be able to execute its growth strategies, and NewGenIvf’s business, financial condition,
and prospects may